Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

Health Consultant June 11, 2024 0

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

from NYT > Health https://ift.tt/dTJFvE7
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )